Japan Diagnostic Testing Market

Japan Diagnostic Testing Market Insights Forecasts to 2035

• The Japan Diagnostic Testing Market Size Was Estimated at USD 10.58 Billion in 2024

• The Market Size is Expected to Grow at a CAGR of Around 4.27% from 2025–2035

• The Japan Diagnostic Testing Market Size is Expected to Reach USD 16.76 Billion by 2035

According to a research report published by Decision Advisors & Consulting, the Japan Diagnostic Testing Market is anticipated to reach USD 16.76 Billion by 2035, growing at a CAGR of 4.27% from 2025–2035. The Japanese diagnostic testing market is driven by an increase in the number of people suffering from chronic diseases. There is also an increase in the demand for diagnosis at an earlier stage of development. The advancements being made in imaging, molecular diagnostics, and lab automation technologies have spurred hospital diagnostic growth through more hospitals implementing AI-enabled Diagnostic Systems, through the increased availability of Point-of-Care diagnostic devices, and through the expansion of Preventive Screening Programs.

Market Overview

The Japanese diagnostic testing market refers to the medical diagnostics industry that performs laboratory testing and imaging assessments in diagnosing and assessing health disorders & forming treatment recommendations. Tests can include imaging diagnostics, laboratory testing, genetics testing, and rapid assessment at the point of care (POC). The market's trend is towards medical precision technology that is increasingly favoured for its clinical application, minimally invasive approach to screening, and the use of digital and artificial intelligence (AI) analytic platforms for diagnostic testing. Key market characteristics include strong investment in healthcare innovation, a highly aging population that requires frequent health monitoring, and fast adoption of advanced diagnostic equipment across hospitals and clinics. Drivers such as increasing cancer screening, growth in infectious disease testing, and improved accessibility through community diagnostic centers are contributing to robust market expansion.

The National Cancer Screening Program, digital healthcare transformation policies, and grants supporting diagnostic technology innovation have further strengthened the diagnostic ecosystem in Japan.

Report Coverage

This research report categorizes the market for the Japan diagnostic testing market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan diagnostic testing market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan diagnostic testing market.

Driving Factor

The Japanese diagnostic testing market is driven by an increased demand for early identification of disease, more companies employing both molecular and genetic testing, and an increased incidence of chronic diseases like cancer, heart disease, and diabetes will directly lead to growth in this area. The new technology available today, including imaging, automated lab systems, and at-home testing, will greatly contribute to increased market growth

Restraining Factor

The Japanese diagnostic testing market faces restraints such as high equipment procurement costs, a shortage of skilled diagnosticians, and Strict regulatory frameworks that may slow technology adoption. Reimbursement restrictions on advanced testing and the increasing cost pressures on the healthcare provider sector could also help restrict the growth of this market.

Market Segmentation

The Japan diagnostic testing market share is categorized by test type, end user, and technology.

• The laboratory testing segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japanese diagnostic testing market is segmented by test type into imaging tests, laboratory tests, molecular diagnostics, point-of-care testing, and others. Among these, the laboratory testing segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by clinical chemistry, hematology, immunology, and microbiology test markets will continue to see a strong increase due to the prevalence of chronic diseases and the increasing demand for routine preventive health screenings, as well as the continuing technological developments related to the introduction of more automated analytical devices that automate laboratory processes.

• The hospital segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japanese diagnostic testing market is segmented by end user into hospitals, diagnostic centers, clinics, and others. Among these, the hospital segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by specific characteristics of this segment include the availability of advanced diagnostic technologies to diagnose complex cases, labs with laboratory and imaging components; the ability to facilitate the flow of a large volume of patients through the strong medical emergency services; and the rapid incorporation of AI-enabled technology into diagnostic practices, which will contribute to the continued expansion of this segment.

• The PCR technology segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japanese diagnostic testing market is segmented by technology into immunoassays, PCR, microbiology, radiology, and others. Among these, the PCR segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by highly accurate pathogen detection, the rising prevalence of genetic and cancer testing, and the expansive use of PCR technologies for diagnosing infectious diseases, supporting segment leadership with regards to accuracy and speed to results, as well as the broadly applicable nature of this technology among all segments of laboratory testing.

Competitive Analysis

The report offers the appropriate analysis of the key organizations/companies involved within the Japan diagnostic testing market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Sysmex Corporation
• Fujifilm Holdings Corporation
• Hitachi Healthcare Systems
• Toshiba Medical Systems
• Shimadzu Corporation
• H.U. Group Holdings
• Canon Medical Systems
• Roche Diagnostics Japan
• Siemens Healthineers Japan
• Philips Japan
• Others

Key Target Audience

•  Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firms
• Venture Capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2025, Fujifilm announced the launch of its next-generation digital diagnostic imaging system designed to provide faster screening and enhanced AI-assisted analysis across major hospitals in Japan.

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the Japan Diagnostic Testing Market based on the segments below:

Japan Diagnostic Testing Market, By Test Type

• Imaging Tests
• Laboratory Tests
• Molecular Diagnostics
• Point-of-Care Testing
• Others

Japan Diagnostic Testing Market, By End User

• Hospitals
• Diagnostic Centers
• Clinics
• Others

Japan Diagnostic Testing Market, By Technology

• Immunoassays
• PCR
• Microbiology
• Radiology
• Others

Frequently Asked Questions (FAQs)

Q: What is the Japan Diagnostic Testing Market size?

A: The Japan Diagnostic Testing Market is expected to grow from USD 10.58 billion in 2024 to USD 16.76 billion by 2035, at a CAGR of 4.27% during 2025–2035.

Q: What factors restrain the Japan Diagnostic Testing Market?

A: Key restraints include high equipment costs, skilled workforce shortages, strict regulatory requirements, and reimbursement limitations.

Q: How is the market segmented by test type?

A: The market is segmented into imaging tests, laboratory tests, molecular diagnostics, point-of-care testing, and others.

Q: Who are the key players in the Japan Diagnostic Testing Market?

A: Major players include Sysmex, Fujifilm, Canon Medical, Siemens Healthineers, Roche Diagnostics, and others